You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
17 June 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) confirmed on Wednesday that it has completed the acquisition of Perfuse Therapeutics Inc.Through this acquisition Bayer now holds full rights to PER-001, a...
17 June 2026 - Medical radioisotopes manufacturer Niowave Inc and Ratio Therapeutics Inc, a clinical-stage pharmaceutical company developing radiopharmaceuticals for cancer treatment, announced on Tuesday a supply agreement for Actinium-225.Under thi...
17 June 2026 - 4E Therapeutics Inc, a neuroscience company developing next-generation treatments for chronic pain, announced on Tuesday that it has been acquired by US pharmaceutical company Eli Lilly and Company (NYSE:LLY).This acquisition combines ...
16 June 2026 - Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc (Nasdaq:INVA) focused on innovative therapies in critical care and infectious disease, said on Tuesday that it has entered into an exclusive distribution and licensing agree...
16 June 2026 - Minghui Pharmaceutical, a late-stage clinical biopharmaceutical company focused on developing innovative therapies for oncology and autoimmune diseases, announced on Monday the presentation of complete Phase I/II clinical data for MHB0...
16 June 2026 - Clinical-stage biotechnology company Kalohexis Inc announced on Monday that data supporting dual melanocortin-3 receptor/melanocortin-4 receptor (MC3R/MC4R) activation as a novel mechanism to drive healthier, more durable weight loss h...
16 June 2026 - Hillhurst Biopharmaceuticals Inc, a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products based on known inhaled therapeutics, announced on Monday that the first subject has been dosed in its Ph...